Freedom Capital Markets Reiterates Buy Rating on iRhythm Technologies, Inc (IRTC)

Market Context

iRhythm Technologies, Inc operates in the Healthcare sector. The stock currently trades at $107.36 with a market capitalization of $5.4B. The stock has declined 37.2% over the past 52 weeks.

Analyst coverage from Freedom Capital Markets provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for iRhythm Technologies, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for iRhythm Technologies, Inc

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 06, 2026	Wells Fargo	Overweight	N/A
Oct 06, 2026	Freedom Capital Markets	Buy	N/A
Oct 05, 2026	Needham	Buy	N/A
Aug 18, 2026	Wells Fargo	Overweight	N/A
Aug 10, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View IRTC Stock Page